Phase I dose-escalation study of endoscopic intratumoral injection of OBP-301 (Telomelysin) with radiotherapy in oesophageal cancer patients unfit for standard treatments
Yasuhiro Shirakawa(Okayama University), Toshiyoshi Fujiwara(Okayama University)
Cited by 66
Related Papers
CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment
|Molecular Cancer Therapeutics|2021|258
AZIN1 RNA editing confers cancer stemness and enhances oncogenic potential in colorectal cancer
|JCI Insight|2018|148
The epithelial-to-mesenchymal transition induced by tumor-associated macrophages confers chemoresistance in peritoneally disseminated pancreatic cancer
|Journal of Experimental & Clinical Cancer Research|2018|111
Risk factors for major morbidity after liver resection for hepatocellular carcinoma
|British journal of surgery|2012|104